The panel of CDC advisers voted 11-0 in favor of adding the RSV shots to the U.S. children’s program and the panel voted 10-0 in favor of supporting the shot for at-risk children in the second RSV season, according to Bloomberg.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AZN:
- 5 Healthcare Stocks to Buy Now, According to Analysts – August 2023
- Zentalis appoints Freeman as Chief Strategy Officer
- AstraZeneca (AZN) Announces Q3 Dividend: Read On for Important Dates
- Ionis Pharmacompletes enrollment for Phase 3 CARDIO-TTRansform study
- AstraZeneca: Enhertu showed clinically meaningful PFS, OS in DESTINY-PanTumor02